Spectacles filter to help migraine sufferers

Article

A new product, MigraLens, designed to filter red and blue light and help migraine sufferers is now available in the UK in a range of branded plano eyewear including fit-overs for presciption glasses.

A new product, MigraLens, designed to filter red and blue light and help migraine sufferers is now available in the UK in a range of branded plano eyewear including fit-overs for presciption glasses.

The flicker and glare absorbing filter has been trialled by its developer, Mediview, with members of the Macular Disease Society and now, Migraine Action too. Lee Tomkins, Director of Migraine Action, a UK charity that offers advice and support to migraine sufferers commented: “Our members have found that MigraLens is able to minimise the problems caused by flicker and glare and we are confident that it will become a useful new addition to existing migraine treatments available to light sensitive sufferers.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.